Citations

Showing 10 of 108104 citations.

Erratum for Marrero Rolon et al., “Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool”
Rolón, Rebecca Marrero, Mandrekar, Jayawant N. , Polo, Erin T., Patel, Robin , Marrero Rolon, Rebecca, Patel, Robin , Cunningham, Scott A.

Mayo Clinic

Journal of Clinical Microbiology | February 16, 2022 | Volume: 60 | Issue: 2 | Pages: No page available

10.1128/jcm.02452-21 | PMID 35170985 Get It

VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION
Salman, Ali R. , Ferenchak, Kevin , Olsen, Timothy W. , Smith, Wendy M. , Salomão, Diva R. , Dalvin, Lauren A. , Dalvin, Lauren A , Ketterling, Rhett P. , McPhail, Ellen Darcy

Mayo Clinic

RETINAL Cases & Brief Reports | February 16, 2022 | Volume: 17 | Issue: 5 | Pages: 572-576

10.1097/icb.0000000000001263 | PMID 37490925 Get It

Purpose: The purpose of this study was to describe an exceedingly rare presentation of secondary vitreoretinal involvement by the uncommon entity “indolent T-cell lymphoproliferative disorder of the gastrointestinal tract” and illustrate the utility of fluorescence in situ hybridization for diagnosis. Methods: This is a case report. Results: A 57-year-old woman with presumed iritis on chronic topical prednisolone acetate presented with increased vitreous opacities in the right eye. She had a history of biopsy-confirmed indolent T-cell lymphoproliferative disorder of the gastrointestinal tract involving the stomach and duodenum, JAK2-rearrangement positive, controlled on maintenance oral methotrexate. Vitreous biopsy was unremarkable with small CD3-positive and CD4-positive and CD20-negative lymphocytes, along with histiocytes and fibroblasts. Immunostains showed CD4 positivity, and fluorescence in situ hybridization revealed a JAK2 gene rearrangement, consistent with the patient's previously diagnosed indolent T-cell lymphoproliferative disorder of the gastrointestinal tract. Intravitreal methotrexate injections were started in the right eye. MRI of the brain and lumbar puncture with cytology, MYD88, IL10, and flow cytometry performed at the time of right eye vitreoretinal lymphoma diagnosis revealed no evidence of central nervous system lymphoma, but subsequent bone marrow biopsy demonstrated 5% involvement by indolent T-cell lymphoproliferative disorder of the gastrointestinal tract, JAK2-rearrangement positive, with a lung nodule on PET computed tomography. She returned 4 months later with fatigue, night sweats, and blurry vision in the left eye with vitreous and anterior chamber cellular infiltration and retinal vasculitis. Conclusion: T-cell vitreoretinal lymphoma is rare, and diagnosis can be challenging. Despite inconclusive cytology in this case, interphase fluorescence in situ hybridization detected a JAK2 gene rearrangement, which confirmed the involvement by indolent T-cell lymphoproliferative disorder of the gastrointestinal tract and prompted appropriate treatment and workup for recurrent systemic or central nervous system lymphoma.
Utilization and in‐hospital complications of catheter ablation for atrial fibrillation in patients with obesity and morbid obesity
Prasitlumkum, Narut , Kaewput, Wisit , Cheungpasitporn, Wisit , Vallabhajosyula, Saraschandra , Jongnarangsin, Krit, Cheungpasitporn, Wisit , Kaewput, Wisit , Vallabhajosyula, Saraschandra , Prasitlumkum, Narut , Chokesuwattanaskul, Ronpichai , Thongprayoon, Charat , Boonpheng, Boonphiphop

Mayo Clinic

Clinical Cardiology | February 16, 2022 | Volume: 45 | Issue: 4 | Pages: 407-416

10.1002/clc.23795 | PMID 35170775 Get It

AbstractBackgroundReal‐world data on atrial fibrillation (AF) ablation outcomes in obese populations have remained scarce, especially the relationship between obesity and in‐hospital AF ablation outcome.HypothesisObesity is associated with higher complication rates and higher admission trend for AF ablation.MethodsWe drew data from the US National Inpatient Sample to identify patients who underwent AF ablation between 2005 and 2018. Sociodemographic and patients' characteristics data were collected, and the trend, incidence of catheter ablation complications and mortality were analyzed, and further stratified by obesity classification.ResultsA total of 153 429 patients who were hospitalized for AF ablation were estimated. Among these, 11 876 obese patients (95% confidence interval [CI]: 11 422–12 330) and 10 635 morbid obese patients (95% CI: 10 200–11 069) were observed. There was a substantial uptrend admission, up to fivefold, for AF ablation in all obese patients from 2005 to 2018 (p < .001). Morbidly obese patients were statistically younger, while coexisting comorbidities were substantially higher than both obese and nonobese patients (p < .01) Both obesity and morbid obesity were significantly associated with an increased risk of total bleeding, and vascular complications (p < .05). Only morbid obesity was significantly associated with an increased risk of ablation‐related complications, total infection, and pulmonary complications (p < .01). No difference in‐hospital mortality was observed among obese, morbidly obese, and nonobese patients.ConclusionOur study observed an uptrend in the admission of obese patients undergoing AF ablation from 2005 through 2018. Obesity was associated with higher ablation‐related complications, particularly those who were morbidly obese.
Contribution of Uremia to Ureaplasma -Induced Hyperammonemia
Fleming, Derek , Patel, Robin , Patel, Robin , Fleming, Derek , Cunningham, Scott A.

Mayo Clinic

Microbiology Spectrum | February 16, 2022 | Volume: 10 | Issue: 1 | Pages: No page available

10.1128/spectrum.01942-21 | PMID 35171026 Get It

Ureaplasma -induced hyperammonemia is a deadly complication affecting around 4% of lung transplant recipients and, to a lesser extent, other solid organ transplant patients. Understanding the underlying mechanisms will inform patient management, potentially decreasing mortality and morbidity. Here, it is shown that uremia is a plausible contributing factor to the pathophysiology of the condition.
Serious Adverse Events With Injectable Fillers: Retrospective Analysis of 7,659 Patient Outcomes
Kern, Jessica A. , Kollipara, Ramya, Hoss, Elika, Boen, Monica , Wu, Douglas C. , Groff, William Frederick, Goldman, Mitchel P, Goldman, Mitchel P.

Mayo Clinic

Dermatologic Surgery | February 16, 2022 | Volume: 48 | Issue: 5 | Pages: 551-555

10.1097/dss.0000000000003409 | PMID 35170541 Get It

BACKGROUND In total, 2.7 million injectable filler treatments were performed in 2019 in the United States. Although generally considered to be a safe treatment modality, adverse events may occur in rare situations. OBJECTIVE Analyze serious adverse events from injectable filler treatments, including infections, cutaneous necrosis, blindness, or delayed-onset nodule formation, spanning 11 years for 3 board-certified dermatologists and review their incidence, management, and outcomes. MATERIALS AND METHODS A retrospective analysis was performed of injectable filler treatments spanning 11 years at a multipractitioner outpatient clinic. Serious adverse events were identified, and treatment measures were documented. A literature search was performed to determine recent trends and outcomes for comparison. RESULTS Between January 2009 and August 2020, 18,013 mL of injectable filler was administered to 7,659 patients. Of the 18,013 mL administered, 74.1% comprised hyaluronic acid derivatives, 19.19% poly-l-lactic acid, and 6.71% calcium hydroxylapatite. Four serious adverse events were identified. Three events were delayed-onset skin nodule formation. One adverse event was related to vascular compromise and subsequent cutaneous necrosis. After appropriate treatment, all adverse events resolved without significant long-term sequelae. CONCLUSION Serious adverse events associated with injectable fillers, when performed by board-certified dermatologists, are extremely rare and can be successfully managed with appropriate treatment.
Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature
Savarino, Vincenzo , Buda, Andrea , Katzka, David A. , Savarino, Edoardo , Savarino, Edoardo , Ghisa, Matteo

Mayo Clinic

Therapeutic Advances in Gastroenterology | February 16, 2022 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/17562848221076888 | PMID 35186122 Get It

Klinefelter syndrome (KS) is a sex aneuploidy abnormality comprised by one additional X chromosome. It occurs in 1:500–1000 male births. As with women, an increased susceptibility to autoimmune diseases is present. We report three cases of coexisting EoE and KS for a prevalence of 2% in our EoE clinic. Possible changes in gene expression in KS are reviewed, some of which may be related to activation of genes located on the X chromosome. We postulate that these X-activated genes in patients with KS yield a greater likelihood of developing EoE because of their genetic predisposition to autoimmune diseases.
Splenic injury is an under-recognized adverse event of in-patient colonoscopy: a nationwide analysis
Umar, Shifa , Brahmbhatt, Bhaumik , Cortés, Pedro , Corral, Juan E. , Bilal, Mohammad , Farraye, Francis A. , Kröner, Paul T.

Mayo Clinic

Endoscopy International Open | February 15, 2022 | Volume: 10 | Issue: 02 | Pages: E178-E182

10.1055/a-1672-3733 | PMID 35178335 Get It

Abstract Background and study aims Splenic injury (SI) during colonoscopy is an underappreciated adverse event. Our aim was to examine the occurrence and outcomes of patients who developed SI after inpatient colonoscopy using a nationwide dataset. Patients and methods Retrospective, observational study using the National Inpatient Sample (NIS) between 2012 and 2018. All patients with ICD9/10CM procedural codes for colonoscopy with or without SI were included. The primary outcome was the association between SI and inpatient colonoscopy. Secondary outcomes were inpatient morbidity, mortality, resource utilization, splenectomy rates, hospital length of stay and total hospital costs and charges. Comparative analyses were performed between patients with and without SI. Multivariate regression analyses were utilized. Results A total of 2,258,040 of inpatient colonoscopies were included. Of these, 240 had associated SI and 25 patients required splenectomy (10.4 %). The incidence of colonoscopy-associated SI remained relatively stable between 2012 and 2018 (0.033 % versus 0.020 %, respectively). The mean age of patients with and without SI was 63.7 and 64.1 years, respectively. The occurrence of SI was calculated as 10.63 cases per 100,000 inpatient colonoscopies. Patients who had associated SI displayed significantly higher odds of inpatient mortality (aOR: 14.45) and ICU stay (aOR: 10.11) compared to those without SI. Conclusions Splenic injury confers significantly higher odds of inpatient mortality, and resource utilization. The incidence of SI related to colonoscopy remained stable during the study period. Although uncommon, SI should be considered when encountering patients with abdominal pain after colonoscopy.
Roles of Tumor Markers in Central Nervous System Germ Cell Tumors Revisited with Histopathology-Proven Cases in a Large International Cohort
Takami, Hirokazu , Graffeo, Christopher S. , Perry, Avital , Nakazato, Yoichi, Saito, Nobuhito , Matsutani, Masao, Ichimura, Koichi , Ichimura, Koichi , Giannini, Caterina , Nishikawa, Ryo , Daniels, David J.

Mayo Clinic

Cancers | February 15, 2022 | Volume: 14 | Issue: 4 | Pages: 979

10.3390/cancers14040979 | PMID 35205726 Get It

The central nervous system germ cell tumor (CNS GCT) is a rare and incompletely understood disease. A major outstanding question in the 2015 consensus document for CNS GCT management was the utility and interpretation of the tumor markers human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP) in the diagnosis of malignant non-germinomatous GCTs (hereafter NGGCTs) prior to treatment. In the current study, we assembled two geographically and ethnically different clinical cohorts from the Mayo Clinic (1988–2017) and the intracranial GCT Genome Analysis Consortium (iGCT Consortium) in Japan to address this question. Patients with both histopathological diagnosis and tumor markers available were eligible for inclusion (n = 162). Biopsy and surgical resection were performed in 85 and 77 cases, respectively. Among 77 resections, 35 demonstrated positivity for HCG, AFP, or both (45%). Seventeen of the marker-positive cases had no malignant non-germinomatous component identified on histopathology, but they were composed strictly of germinoma, teratoma, or both (49%). One embryonal carcinoma was the only marker-negative NGGCT in the study sample. Among 85 biopsies, 18 were marker positive (21%). Seven of these patients had no malignant non-germinomatous component on histopathology, suggesting the potential limitations of limited tissue sample volumes. Neither histopathological diagnosis nor tumor markers alone reliably diagnose NGGCTs due to the secretion of HCG and AFP by germinomas and teratomas. Treatment planning should incorporate integrated histopathological and laboratory-based diagnosis to optimize diagnostic and treatment strategies for this unusual and histologically heterogeneous tumor.
Examining the Feasibility and Functionality of Common Analysis Methods for Longitudinal Data with Binary Outcomes
Dueck, Amylou C. , Dueck, A. C. , Zaniletti, Isabella , DeWees, T.A.

Mayo Clinic

No container title available | February 15, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1299793/v1 Get It

Abstract Background Previous literature often indicates that binary longitudinal data, such as responder analysis with patient-reported outcomes to evaluate treatment risks and benefits in cancer randomized controlled trials, need complex statistical approaches for a thorough evaluation of the treatment effect and consequently elaborated clinical design and power calculation for prospective trials. This simulated analysis aims to evaluate six common statistical techniques used for binary longitudinal data to explore the feasibility and overall functionality of these methods in comparison to more complex modeling techniques. Methods We simulated data to represent a typical clinical trial design, with dichotomous outcome, and treatment vs control group at three waves T1, T2, and T3. We evaluated five sample size conditions ranging from small to large with 1,000 replicates each. We then evaluated results from six statistical techniques (Generalized linear model [GLM] with generalized estimating equations [GEE], Generalized linear mixed model [GLMM], Logistic regression, Cochran-Mantel-Haenszel [CMH], Chi-square, and Fisher’s Exact test) and their ability in detecting difference between treatment groups under different conditions. Results While less elaborated models always achieved convergence, the convergence rate of GLMM with unstructured covariance matrix ranged from 7–43%. The proportion of detected significant differences between control and treatment expectedly increased with the increasing of the sample size but remained somewhat similar across modeled outcome and sample size scenarios. Conclusions Overall results indicated that, with careful consideration, straightforward modelling approaches which require less assumptions in design and power calculation are sufficient to ensure meaningful, adequately powered, evaluation of treatment effect.